Abstract

Objectives

To evaluate the need and feasibility of a nurse-led antimicrobial stewardship (AMS) programme in two Australian residential aged care homes (RACHs) to inform a stepped-wedged, cluster randomized controlled trial (SW-cRCT).

Methods

A mixed-methods pilot study of a nurse-led AMS programme was performed in two RACHs in Victoria, Australia (July–December 2019). The AMS programme comprised education, infection assessment and management guidelines, and documentation to support appropriate antimicrobial use in urinary, lower respiratory and skin/soft tissue infections. The programme was implemented over three phases: (i) pre-implementation education and integration (1 month); (ii) implementation of the intervention (3 months); and (iii) post-intervention evaluation (1 month). Baseline RACH and resident data and weekly infection and antimicrobial usage were collected and analysed descriptively to evaluate the need for AMS strategies. Feedback on intervention resources and implementation barriers were identified from semi-structured interviews, an online staff questionnaire and researcher field notes.

Results

Six key barriers to implementation of the intervention were identified and used to refine the intervention: aged care staffing and capacity; access to education; resistance to practice change; role of staff in AMS; leadership and ownership of the intervention at the RACH and organization level; and family expectations. A total of 61 antimicrobials were prescribed for 40 residents over the 3 month intervention. Overall, 48% of antibiotics did not meet minimum criteria for appropriate initiation (respiratory: 73%; urinary: 54%; skin/soft tissue: 0%).

Conclusions

Several barriers and opportunities to improve implementation of AMS in RACHs were identified. Findings were used to inform a revised intervention to be evaluated in a larger SW-cRCT.

Details

Title
Pilot study to evaluate the need and implementation of a multifaceted nurse-led antimicrobial stewardship intervention in residential aged care
Author
Natali Jokanovic 1 ; Lee, Sue J 1 ; Haines, Terry 2 ; Hilmer, Sarah N 3 ; Yun-Hee Jeon 4   VIAFID ORCID Logo  ; Travis, Laura 1 ; Ayton, Darshini 5 ; Watson, Eliza 1   VIAFID ORCID Logo  ; Tsindos, Tess 5 ; Stewardson, Andrew J 1 ; Stuart, Rhonda L 6 ; Cheng, Allen C 7 ; Peel, Trisha N 1 ; Peleg, Anton Y 1   VIAFID ORCID Logo  ; Peleg, Anton; Cheng, Allen; Peel, Trisha; Holt, Kathryn; Hilmer, Sarah; Stewardson, Andrew; Stuart, Rhonda; Wilson, Daniel; Trauer, James; Cruickshank, Marilyn; De Maio, Nicola; Roney, Janine; Wisniewski, Jessica

 Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University , Melbourne, Victoria , Australia 
 School of Primary and Allied Health Care, Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria , Australia 
 Departments of Clinical Pharmacology and Aged Care, Kolling Institute of Medical Research, Royal North Shore Hospital, Faculty of Medicine and Health, The University of Sydney , Sydney, New South Wales , Australia 
 Sydney Nursing School, Faculty of Medicine and Health, The University of Sydney , Sydney, New South Wales , Australia 
 Health and Social Care Unit, School of Public Health and Preventive Medicine, Monash University , Clayton Victoria , Australia 
 Public Health and Infection Prevention, Monash Health, Monash Medical Centre , Clayton, Victoria , Australia 
 Monash Infectious Diseases, Monash Health, Monash Medical Centre , Clayton, Victoria , Australia 
Publication year
2024
Publication date
Feb 2024
Publisher
Oxford University Press
e-ISSN
26321823
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3170554491
Copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.